# A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

> **NCT05978037** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 58 (estimated)

## Conditions studied

- Malaria
- Malaria,Falciparum
- Parasitic Disease
- Vector Borne Diseases
- Infections

## Interventions

- **BIOLOGICAL:** RH5.1 and/or RH5.2-VLP with Matrix-M

## Key facts

- **NCT ID:** NCT05978037
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-18
- **Primary completion:** 2026-01-10
- **Final completion:** 2026-03-10
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978037, "A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05978037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*